CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Remedium Lifecare Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Remedium Lifecare Ltd
116-C Focal Point
Phone: +91 2228505005p:+91 2228505005 MUMBAI, 400059  India Ticker: 539561539561
Business Summary
Remedium Lifecare Limited is a pharmaceutical company, which is aligned across two business verticals, such as Products and Services. Products business comprises the trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovators and generic pharmaceutical players in both domestic and international markets, including the regulated markets. It is engaged in the business of trading in Advanced Pharmaceutical Intermediates, API’s and other pharma products used, including Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine, Ethyl Acetate, Hydrazine Hydrate, IPA, Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide. It also manufactures various APIs, such as Atorvastatin Calcium (Amorphous), Citalopram Hydrochloride and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
Yes------

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer Ashish D.Parkar
Whole Time Company Secretary, Compliance Officer Neeraj R.Yadav 8/14/2024 8/14/2024
Whole Time Director Adarsh D.Munjal 9/5/2023 9/5/2023
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 7 (As of 3/31/2024)
Outstanding Shares: 403,200,000 (As of 9/30/2024)
Shareholders: 15,587
Stock Exchange: BOM
Fax Number: +91 1615011017


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025